The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 18 September 2006 doi:10.1084/jem.20060921
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 10, 2293-2303
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2211K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gadola, S. D.
Right arrow Articles by Cerundolo, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gadola, S. D.
Right arrow Articles by Cerundolo, V.
Related Collections
Right arrowRelated Articles
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases

Stephan D. Gadola1, Jonathan D. Silk1, Aruna Jeans2, Petr A. Illarionov3, Mariolina Salio1, Gurdyal S. Besra3, Raymond Dwek2, Terry D. Butters2, Frances M. Platt2, and Vincenzo Cerundolo1

1 Weatherall Institute of Molecular Medicine, Tumour Immunology Group, John Radcliffe Hospital, Oxford OX3 9DS, England, UK
2 Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford OX1 3QU, England, UK
3 School of Biosciences, University of Birmingham, Birmingham B15 2TT, England, UK

CORRESPONDENCE Vincenzo Cerundolo: vincenzo.cerundolo{at}imm.ox.ac.uk

Glycolipid ligands for invariant natural killer T cells (iNKT cells) are loaded onto CD1d molecules in the late endosome/lysosome. Accumulation of glycosphingolipids (GSLs) in lysosomal storage diseases could potentially influence endogenous and exogenous lipid loading and/or presentation and, thus, affect iNKT cell selection or function. The percentages and frequency of iNKT cells were reduced in multiple mouse models of lysosomal GSL storage disease, irrespective of the specific genetic defect or lipid species stored. Reduced numbers of iNKT cells resulted in the absence of cytokine production in response to {alpha}-galactosylceramide ({alpha}-GalCer) and reduced iNKT cell–mediated lysis of wild-type targets loaded with {alpha}-GalCer. The reduction in iNKT cells did not result from defective expression of CD1d or a lack of antigen-presenting cells. Although H-2 restricted CD4+ T cell responses were generally unaffected, processing of a lysosome-dependent analogue of {alpha}-GalCer was impaired in all the strains of mice tested. These data suggest that GSL storage may result in alterations in thymic selection of iNKT cells caused by impaired presentation of selecting ligands.


Abbreviations used: {alpha}-GalCer, {alpha}-galactosylceramide; BMDC, bone marrow–derived DC; Gal(1->2)GalCer, galactosyl({alpha}1->2) galactosylceramide; GSL, glycosphingolipid; iGb3, isoglobotrihexosylceramide; iNKT cells, invariant natural killer T cells; LOTS, late-onset Tay-Sachs disease; NPC1, Niemann-Pick disease type C1.

S.D. Gadola, J.D. Silk, and A. Jeans contributed equally to this work.

S.D. Gadola's current address is Clinic for Rheumatology and Clinical Immunology/Allergology, University Hospital of Bern, CH-3010 Bern, Switzerland.

F.M. Platt and A. Jeans's current address is Dept. of Pharmacology, University of Oxford, Oxford OX1 3QT, England, UK.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Chewing the fat on natural killer T cell development
Dale I. Godfrey, Malcolm J. McConville, and Daniel G. Pellicci
J. Exp. Med. 2006 203: 2229-2232. [Abstract] [Full Text] [PDF]

Defective fat storage
Ruth Williams
J. Exp. Med. 2006 203: 2218b. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS